These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4054451)

  • 1. Use of theophylline in infants.
    FDA Drug Bull; 1985 Aug; 15(2):16-7. PubMed ID: 4054451
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns about the Food and Drug Administration guidelines for neonatal theophylline dosing.
    Gal P; Gilman JT
    Ther Drug Monit; 1986; 8(1):1-3. PubMed ID: 3961885
    [No Abstract]   [Full Text] [Related]  

  • 3. New FDA guidelines for theophylline dosing in infants.
    Murphy JE; Erkan NV; Fakhreddine F
    Clin Pharm; 1986 Jan; 5(1):16. PubMed ID: 3948482
    [No Abstract]   [Full Text] [Related]  

  • 4. Inadequacy of FDA dosing guidelines for theophylline use in neonates.
    Gilman JT; Gal P
    Drug Intell Clin Pharm; 1986 Jun; 20(6):481-4. PubMed ID: 3720540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criticism of FDA recommendations for theophylline dosage.
    Murphy JE; Ward ES
    N Engl J Med; 1980 Sep; 303(13):760-1. PubMed ID: 7402287
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentially toxic theophylline dose recommendations.
    Hendeles L
    Pediatrics; 1978 Aug; 62(2):275-6. PubMed ID: 693169
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peculiarities of the pharmacokinetics and pharmacodynamics of theophylline in children].
    Berdel D; Heimann G
    Wien Klin Wochenschr; 1984 Aug; 96(16):616-21. PubMed ID: 6516414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic, hormonal and nutritional effects of long-term theophylline therapy in preterm infants: a case-control study].
    Colonna F; Pahor T; de Vonderweid U; Radillo L; Tamaro G
    Pediatr Med Chir; 1995; 17(4):345-8. PubMed ID: 7491331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity.
    Bhatt-Mehta V; Johnson CE; Donn SM; Spadoni V; Schork MA
    Pharmacotherapy; 1995; 15(2):246-50. PubMed ID: 7624272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved efficacy and safety of theophylline in the control of airways hyperreactivity.
    Hendeles L; Weinberger M
    Ann Allergy; 1982 Nov; 49(5):247-56. PubMed ID: 6128950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical pharmacology of theophylline].
    Reinhardt D; Richter O; Schaefers M; Becker B
    Internist (Berl); 1982 Dec; 23(12):728-35. PubMed ID: 6761302
    [No Abstract]   [Full Text] [Related]  

  • 12. Theophylline--clinical pharmacokinetics and therapeutic drug monitoring.
    Dahlqvist R; Billing B; Ripe E
    Eur J Respir Dis Suppl; 1984; 136():81-94. PubMed ID: 6587995
    [No Abstract]   [Full Text] [Related]  

  • 13. Theophylline infusion for prevention of apnea of prematurity.
    Rao R; Narang A
    Indian Pediatr; 1993 Jun; 30(6):823-5. PubMed ID: 8132273
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective evaluation of two dosing equations for theophylline in premature infants.
    Bhatt-Mehta V; Donn SM; Schork MA; Reed S; Johnson CE
    Pharmacotherapy; 1996; 16(5):769-76. PubMed ID: 8888073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-dose theophylline.
    Milsap RL; Krauss AN; Auld PA
    Semin Perinatol; 1981 Oct; 5(4):321-5. PubMed ID: 7302606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyponatremia and theophylline in very low birthweight premature infants].
    Sann L; Cottancin G; Bourgeois J; Bory C; Baltassat P; Bethenod M
    Arch Fr Pediatr; 1982; 39(7):419-22. PubMed ID: 7149887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of unusual theophylline elimination in an infant.
    Ohrt DW; Liggett JS
    S D J Med; 1984 Oct; 37(10):5-11. PubMed ID: 6595804
    [No Abstract]   [Full Text] [Related]  

  • 18. Revised FDA labeling guideline for theophylline oral dosage forms.
    Hendeles L; Jenkins J; Temple R
    Pharmacotherapy; 1995; 15(4):409-27. PubMed ID: 7479193
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical pharmacology of theophylline in the treatment of asthma].
    Cuena Boy R; Honorato Pérez JM; Azanza Perea JR
    Rev Med Univ Navarra; 1982 Sep; 26(3):175-80. PubMed ID: 7170535
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of transdermal theophylline pharmacokinetics in neonates.
    Micali G; Bhatt RH; Distefano G; Caltabiano L; Cook B; Fischer JH; Solomon LM; West DP
    Pharmacotherapy; 1993; 13(4):386-90. PubMed ID: 8361866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.